StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) stock

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Emmaus Life Sciences cash

Cash and short-term investments held at the end of each period.

Emmaus Life Sciences's cash was $2.81M at Jun 30, 2026. For fiscal 2025 it was $2.13M, up 53.1% from the year before. Over ten years it grew 5.5% a year on average. The highest annual figure on record is $29.70M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.13M+53.1%
FY2024Dec 31, 2024$1.39M-45.5%
FY2023Dec 31, 2023$2.55M+26.0%
FY2022Dec 31, 2022$2.02M-11.3%
FY2021Dec 31, 2021$2.28M-8.4%
FY2020Dec 31, 2020$2.49M-91.6%
FY2019Dec 31, 2019$29.70M+445.0%
FY2017Sep 30, 2017$5.45M+1612.4%
FY2016Sep 30, 2016$318.20K-26.4%
FY2015Sep 30, 2015$432.10K-65.2%
FY2014Sep 30, 2014$1.24M-2.6%
FY2013Sep 30, 2013$1.27M+16440.3%
FY2012Sep 30, 2012$7.70K-89.5%
FY2011Sep 30, 2011$73.60K+32.9%
FY2010Sep 30, 2010$55.40K-94.4%
FY2009Sep 30, 2009$988.10K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$2.81M+216.9%
Q1 FY2026CQ1 2026Mar 31, 2026$1.07M-22.8%
Q4 FY2025CQ4 2025Dec 31, 2025$2.13M+69.5%
Q3 FY2025CQ3 2025Sep 30, 2025$293.00K-80.8%
Q2 FY2025CQ2 2025Jun 30, 2025$886.00K-48.2%
Q4 FY2024CQ4 2024Dec 31, 2024$1.39M-45.5%
Q3 FY2024CQ3 2024Sep 30, 2024$1.26M-16.6%
Q2 FY2024CQ2 2024Jun 30, 2024$1.53M+12.0%
Q1 FY2024CQ1 2024Mar 31, 2024$1.71M-3.5%
Q4 FY2023CQ4 2023Dec 31, 2023$2.55M+26.0%
Q3 FY2023CQ3 2023Sep 30, 2023$1.51M+27.7%
Q2 FY2023CQ2 2023Jun 30, 2023$1.36M+38.6%
Q1 FY2023CQ1 2023Mar 31, 2023$1.77M+118.2%
Q4 FY2022CQ4 2022Dec 31, 2022$2.02M-11.3%
Q3 FY2022CQ3 2022Sep 30, 2022$1.18M-49.2%
Q2 FY2022CQ2 2022Jun 30, 2022$982.00K-41.2%
Q1 FY2022CQ1 2022Mar 31, 2022$813.00K-78.4%
Q4 FY2021CQ4 2021Dec 31, 2021$2.28M-8.4%
Q3 FY2021CQ3 2021Sep 30, 2021$2.32M-53.1%
Q2 FY2021CQ2 2021Jun 30, 2021$1.67M-94.0%
Q1 FY2021CQ1 2021Mar 31, 2021$3.76M-89.8%
Q4 FY2020CQ4 2020Dec 31, 2020$2.49M-91.6%
Q3 FY2020CQ3 2020Sep 30, 2020$4.95M-86.2%
Q2 FY2020CQ2 2020Jun 30, 2020$28.04M-37.8%
Q1 FY2020CQ1 2020Mar 31, 2020$36.98M+578.7%
Q4 FY2019CQ4 2019Dec 31, 2019$29.70M+7155.8%
Q3 FY2019CQ3 2018Jun 30, 2019$35.84M+1942.7%
Q2 FY2019CQ2 2018Mar 31, 2019$45.11M+4203.0%
Q4 FY2017CQ3 2017Sep 30, 2017$5.45M+1612.4%
Q3 FY2017CQ2 2017Jun 30, 2017$409.30K-5.0%
Q2 FY2017CQ1 2017Mar 31, 2017$1.75M+298.5%
Q1 FY2017CQ4 2016Dec 31, 2016$1.05M+27.3%
Q4 FY2016CQ3 2016Sep 30, 2016$318.20K-26.4%
Q3 FY2016CQ2 2016Jun 30, 2016$430.80K+203.8%
Q2 FY2016CQ1 2016Mar 31, 2016$440.20K+42.0%
Q1 FY2016CQ4 2015Dec 31, 2015$823.80K+84.8%
Q4 FY2015CQ3 2015Sep 30, 2015$432.10K–
Q3 FY2015CQ2 2015Jun 30, 2015$141.80K–
Q2 FY2015CQ1 2015Mar 31, 2015$310.00K–
Q1 FY2015CQ4 2014Dec 31, 2014$445.70K–

More Emmaus Life Sciences figures

See a number that looks wrong?